← Back to S&P 500 Dashboard
CVS
SELLCVS Health Corporation
Healthcare · Rank #429 · Analyzed Apr 20, 2026
$77.30
Current Price
$119.97
Intrinsic Value
+162.7%
Upside/Downside
1/10
Score
1/5
Quality
Analysis Summary
Valuation Consensus1/3 methods agree
Quality Score1/5.0
Framework RatingSELL
Price vs Intrinsic ValueUndervalued by 162.7%
Fair Value Range
Low$18.32
Base (IV)$119.97
High$203.07
Entry Points
Conservative$18.32
Moderate$69.15
Aggressive$119.97
Quality & Moat Breakdown
Return on Equity2.3% → 0/1.0
Debt LevelD/E 106 → 0/1.0
Revenue QualityGrowth 7.9%, margin Δ-0.0% +recovery → 1.0/1.0
Moat Strength1.5/5 → 0/1.0
Profit Margins0.4% → 0/1.0
Methodology
This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.
Learn how this framework works →This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.